This study is currently not recruiting participants.

ERCP-related bleeding in the era of multiple antiplatelet agents

Not Recruiting
100 years or below
All
Phase N/A
1 Location

Brief description of study.

The purpose of this study is to determine the true incidence of ERCP-related bleeding among those patients who are taking anti-platelet agents, especially in the era of multiple agents, and to compare the incidence of ERCP-related bleeding among patients who are taking no anti-platelet agents versus aspirin versus a single anti-platelet agents other than aspirin versus multiple anti-platelet agents.

Detailed description of study

The purpose of this study is to determine the true incidence of ERCP-related bleeding among those patients who are taking anti-platelet agents, especially in the era of multiple agents, and to compare the incidence of ERCP-related bleeding among patients who are taking no anti-platelet agents versus aspirin versus a single anti-platelet agents other than aspirin versus multiple anti-platelet agents.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: ERCP
  • Age: 100 years or below
  • Gender: All
Updated on 22 Jun 2016. Study ID: 1606176507

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team